PPE News and Research

RSS

Minnesota hospitals, health systems develop coordinated strategy to care for Ebola patients

The Minnesota Hospital Association announced today that hospitals and health systems from around the state have developed a coordinated strategy to care for Ebola patients in Minnesota. Under the plan, all hospitals in the state will continue to be prepared to detect, isolate and initially care for suspected Ebola patients.

25 Oct 2014

Bridgestone Group to donate $1M to combat Ebola outbreak in Liberia

The Bridgestone Group (Bridgestone) today announced it will donate one million dollars (USD) to critical efforts underway in Liberia and the region to combat the Ebola outbreak.

30 Sep 2014

Improper removal of personal protective gear increases risk for Ebola health care workers

A team of American infectious disease and critical care experts is alerting colleagues caring for Ebola patients that how they remove their personal protective gear can be just as crucial as wearing it to prevent exposure to the deadly virus.

10 Sep 2014

Longer looks: Kentucky is health law poster child; how to negotiate a lower medical bill; the Ebola outbreak up close

About a year ago, on Aug. 22, a team of inspectors from the Centers for Medicare and Medicaid Services (CMS) unit of the U.S. Department of Health and Human Services arrived in Frankfort, Ky., to see if the people working out of a nondescript warehouse there were going to be able to pull off the launch of Kentucky's Obamacare health-insurance exchange.

8 Aug 2014

Phase I/II study shows safety and efficacy of VB-111 in patients with rGBM

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced clinical data demonstrating the utility of VB-111's in targeted cancer treatment.

3 Jun 2013

UW researcher receives Dr. Harry L. Galanty Young Investigator Award

University of Washington researcher Jessie Fudge, MD received the Dr. Harry L. Galanty Young Investigator's Award for excellence in sports medicine research at the 21st American Medical Society for Sports Medicine Annual Meeting in Atlanta, Ga. on April 24, 2012.

26 Apr 2012

Positive results from Puma's neratinib Phase II trials presented at CTRC-AACR San Antonio Breast Cancer Symposium

Puma Biotechnology, Inc., a development stage biopharmaceutical company, announced that results from ongoing Phase II clinical trials of Puma's investigational drug PB272 (neratinib) were presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium that is currently taking place in San Antonio, Texas.

9 Dec 2011

Safe Kids USA to host Youth Sports Safety Clinics

With many young school athletes working hard this month to prepare for fall sports, Safe Kids USA is hosting Youth Sports Safety Clinics across the country to educate parents and coaches on how to keep children safe and prevent sports injuries, including heat-related illnesses. Nearly 3/4 of U.S. households have at least one child who plays organized sports.

4 Aug 2011

Novel use of duct tape in infection prevention saves $110,000 annually

The Trinity Infection Prevention team from Iowa/Illinois Trinity Medical Center has come up with the novel idea of using duct tape to reduce infections and save up to $110,000. For this they received the Blue Ribbon Abstract Award. They presented their work, “The Red Box Strategy: An Innovative Method to Improve Isolation Precaution Compliance and Reduce Costs” which received the designation at the Association for Professionals in Infection Control and Epidemiology's 2011 Annual Conference and International Meeting June27-29 in Baltimore.

29 Jun 2011

Promising results from Exelixis' cabozantinib phase 2 trial against metastatic ovarian cancer

Exelixis, Inc. reported longer follow-up data from a fully enrolled cohort of patients with advanced epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube carcinoma treated with cabozantinib (XL184) in an ongoing phase 2 adaptive randomized discontinuation trial. Cabozantinib shows promising activity in these patients independent of prior response to platinum-based therapies.

6 Jun 2011

Journal of Clinical Oncology publishes Exelixis' cabozantinib phase 1 trial results in lymphoma

Exelixis, Inc. today announced the results of the phase 1 clinical trial of cabozantinib in patients with advanced solid tumors or lymphoma have been published in the current issue of the Journal of Clinical Oncology.

24 May 2011

Merck receives Health Canada approval for GARDASIL to treat HPV in women upto age 45

Today, Merck announced that Health Canada has extended the indication of GARDASIL in women up to the age of 45. Merck's HPV vaccine is now approved for girls and women nine through 45 years of age for the prevention of cervical cancer, vulvar and vaginal cancers, precancerous lesions and genital warts caused by the Human Papillomavirus types 6, 11, 16, 18. Previously, GARDASIL was approved in girls and women nine through 26.

26 Apr 2011

Exelixis reports interim data of XL184 for metastatic castration-resistant prostate cancer

Exelixis, Inc. today reported interim data from the cohort of patients with metastatic castration-resistant prostate cancer (CRPC) treated with XL184 in an ongoing phase 2 adaptive randomized discontinuation trial (RDT).

18 Nov 2010

Exelixis reports interim data from phase 2 RDT trial for epithelial ovarian cancer

Exelixis, Inc. today reported interim data from the cohort of patients with advanced epithelial ovarian cancer, primary peritoneal, or fallopian tube carcinoma treated with XL184 in an ongoing phase 2 adaptive randomized discontinuation trial (RDT).

18 Nov 2010

Stryker acquires Porex Surgical

Stryker Corporation announced today the acquisition of privately-held Porex Surgical, a division of Porex Corporation. Porex Surgical is a developer, manufacturer and distributor of bioimplantable porous polyethylene products (PPE) for use primarily in reconstructive surgery of the head and face.

From Stryker 30 Oct 2010

Flu shots, heart attacks and flu prevention guidelines

According to a new British study yearly flu shots may protect against heart attacks, and the earlier in the season a shot is given the greater the protection. Niroshan Siriwardena, a professor of primary and pre-hospital health care at the University of Lincoln said, “The risk of getting a heart attack was reduced by 19 percent for those who had a vaccination in the past year.”

21 Sep 2010

Survey finds high level of noncompliance with PPE protocols among safety professionals

Nearly all of the safety professionals in a survey released today said that workers in their organizations had at some point failed to wear the necessary safety equipment while on the job. An exceedingly high 98 percent of respondents who attended the recent American Society of Safety Engineers (ASSE) show in Baltimore answered "yes" when asked if they had observed workers not wearing safety equipment when they should have been, according to the survey, which was conducted by Kimberly-Clark Professional.

12 Aug 2010

Noveko RD2 antimicrobial respirators obtain FFP2 classification

Noveko International Inc. is pleased to announce that its subsidiary Noveko Inc. has obtained FFP2 classification for its new model of antimicrobial respirators and can now bring them to market in all countries throughout the European Union. These respirators will be marketed as Noveko RD2 antimicrobial respirators.

29 Jul 2010

CPTC offers training program for firefighters to help reduce health-related deaths and injuries

Firefighter deaths due to heart attacks may not be due to bad diets, but from exposure to hydrogen cyanide in fire smoke. Nationally, six firefighters have literally dropped dead from heart attacks after coming off of a shift of smoky fires and more than 100 were treated or hospitalized for smoke inhalation since January 1.

21 Jun 2010

State of Vermont implements Upp Technology's emergency management software

Upp Technology, a global provider of IT staffing services, implemented its irms|EM™ (Emergency Management) software for the State of Vermont within three weeks of selection of the solution. The software helped the State’s RSS (Receive, Stage, & Store) Warehouse become operational following just one day of training and distribute more than 2,000 piece of H1N1 Personal Protection Equipment (PPE) inventory to hospitals throughout the state.

15 Dec 2009